← All Sponsors

SPONSOR

Y-mAbs Therapeutics

Total Trials

1

Recruiting

1

Phases

Phase 1

Conditions studied: SCLC Malignant Melanoma Sarcoma High Risk Neuroblastoma

NCT05130255 Phase 1

GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2